BODE Index for COPD Survival
The BODE Index is a multidimensional score that predicts COPD mortality using body mass index, airflow obstruction, dyspnea, and exercise capacity.
Indications for Use
Estimate survival in symptomatic, stable COPD to guide prognosis, transplant referral, and intensity of follow‑up. It applies to ambulatory patients with confirmed airflow obstruction and integrates BMI, FEV1, dyspnea, and 6‑minute walk distance. It provides stronger mortality discrimination than FEV1 alone (C‑statistic 0.74 vs 0.65 in a 625‑patient validation cohort 1 [Level I evidence]). Also useful for tracking progression and response to interventions (e.g., pulmonary rehabilitation).
Insights & Cautions
Higher scores indicate higher mortality risk, with each 1‑point increase raising death risk by 34% 1 [Level I evidence]. Validated across cohorts and superior to FEV1 alone.
- May underperform when comorbidities dominate; adding COTE improves prediction 2 [Level II evidence].
- Requires accurate 6‑minute walk testing; performance varies with demographic and disease heterogeneity.